Cargando…

Editorial: Pharmacological and Biochemical Perspectives of Kinase Inhibitors in Cancer and COVID-19 Therapeutics, Volume I

Detalles Bibliográficos
Autores principales:	Chandrasekaran, Balakumar, Saravanan, Muthupandian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240733/ https://www.ncbi.nlm.nih.gov/pubmed/35784709 http://dx.doi.org/10.3389/fphar.2022.916324

Ejemplares similares

Editorial: Pharmacological and biochemical perspectives of kinase inhibitors in cancer and COVID-19 therapeutics
por: Chandrasekaran, Balakumar, et al.
Publicado: (2023)

Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A review
por: Jain, Nem Kumar, et al.
Publicado: (2023)

Editorial: Purinergic pharmacology, Volume II
por: Ciruela, Francisco, et al.
Publicado: (2023)

Editorial: Anti-cancer bioactive molecules from microbial sources
por: Mishra, Bishwambhar, et al.
Publicado: (2023)

Editorial: Herbal medicines for gastrointestinal and hepatic diseases - novel pharmacological and toxicological approaches, Volume I
por: Hasnat, Muhammad, et al.
Publicado: (2023)

Emerging Therapeutic Approaches to Combat COVID-19: Present Status and Future Perspectives
por: Vivekanandhan, Karthik, et al.
Publicado: (2021)

Editorial: Imaging technology in oncology pharmacological research, volume II
por: Zeng, Qi, et al.
Publicado: (2022)

Editorial: Hydrogen sulfide: Physiology, Pharmacology and Toxicology, Volume II
por: Bian, Jin-Song
Publicado: (2022)

Editorial: Pharmacological approaches targeting neutrophilic inflammation: Volume II
por: Sokolov, Alexey V., et al.
Publicado: (2022)

Editorial: Psychedelic sociality: Pharmacological and extrapharmacological perspectives
por: Roseman, Leor, et al.
Publicado: (2022)

Editorial: Chronic inflammation and pharmacological interventions in cardiovascular diseases, volume II
por: Yan, Aiwei, et al.
Publicado: (2023)

Editorial: Therapeutic drug monitoring (TDM): a useful tool for pediatric pharmacology applied to routine clinical practice, Volume II
por: Simeoli, Raffaele
Publicado: (2023)

Editorial: Vascular smooth muscle cell fate and vascular remodeling: Mechanisms, therapeutic targets, and drugs, volume I
por: Wang, Qilong, et al.
Publicado: (2022)

Kinase Inhibitors as Potential Therapeutic Agents in the Treatment of COVID-19
por: Naik, Rajashri R., et al.
Publicado: (2022)

Editorial: Toxicity Mechanism and Clinical Features of PD-1/PD-L1 Inhibitors in Treatment of Cancer, Volume I
por: Kong, Xiangyi, et al.
Publicado: (2022)

Editorial: Purinergic Pharmacology
por: Ciruela, Francisco, et al.
Publicado: (2019)

Editorial: Pharmacology of autoimmune and neuroinflammatory disease from a preclinical and clinical perspective
por: Šíma, Martin, et al.
Publicado: (2023)

Editorial: The inaugural Monash international health science and technology conference: pharmacology perspectives
por: Khaw, Kooi Yeong, et al.
Publicado: (2023)

Editorial: Novel therapeutic approaches for the treatment of ocular disease, Volume II
por: Thermos, Kyriaki, et al.
Publicado: (2022)

Editorial: IBD Management—Novel Targets and Therapeutic Perspectives
por: Antonioli, Luca, et al.
Publicado: (2020)

Editorial: II Bio.natural-bioactive natural products research meeting: Pharmacology perspectives
por: Rijo, Patricia, et al.
Publicado: (2022)

Editorial: Metal-complexed molecules of natural and synthetic origin: Pharmacological advances and therapeutic applications
por: Mohapatra, Ranjan K., et al.
Publicado: (2022)

Editorial: Antimycobacterial drug discovery: molecular therapeutics and target identification, Volume II
por: Gunosewoyo, Hendra, et al.
Publicado: (2023)

Editorial: Applications of Nanobiotechnology in Pharmacology
por: Qi, Baowen, et al.
Publicado: (2019)

Editorial: Innovation in ocular pharmacology
por: Gozzo, Lucia, et al.
Publicado: (2023)

Editorial: Evolution in respiratory pharmacology
por: Ruaro, Barbara, et al.
Publicado: (2023)

Therapeutics of Charcot neuroarthropathy and pharmacological mechanisms: A bone metabolism perspective
por: Liu, Liang, et al.
Publicado: (2023)

Editorial: Modulating lymphatic vascular growth in disease: current and potential pharmacological approaches for prevention and treatment, Volume II
por: Trevaskis, Natalie L., et al.
Publicado: (2023)

Editorial: Contemporary Perspective on 5-HT(2C) Receptor Function and Its Pharmacological Targeting
por: De Deurwaerdère, Philippe, et al.
Publicado: (2020)

Editorial: MSPP 34th scientific meeting: Pharmacological perspectives on natural products in drug discovery
por: Shaikh, Mohd. Farooq, et al.
Publicado: (2022)

Editorial: Kappa opioid receptors revealed: Disentangling the pharmacology to open up new therapeutic strategies
por: Walwyn, Wendy Margaret, et al.
Publicado: (2022)

Editorial: Natural products as an emerging therapeutic alternative for the treatment of anxiety and depression, Volume II
por: Khan, Ajmal, et al.
Publicado: (2022)

Editorial: New insights into renal fibrosis and therapeutic effects of natural products volume II
por: Chen, Dan-Qian, et al.
Publicado: (2022)

Editorial: In vivo Imaging in Pharmacological Research
por: Beckmann, Nicolau, et al.
Publicado: (2017)

Editorial: Network Pharmacology and Traditional Medicine
por: Lai, Xinxing, et al.
Publicado: (2020)

Editorial: The Pharmacology of Kratom and Its Alkaloids
por: Grundmann, Oliver, et al.
Publicado: (2022)

Editorial: Insights in Inflammation Pharmacology: 2021
por: Patrignani, Paola, et al.
Publicado: (2022)

Editorial: Women in Inflammation Pharmacology: 2021
por: Patrignani, Paola
Publicado: (2022)

Editorial: Insights in renal pharmacology: 2021
por: Perico, Norberto, et al.
Publicado: (2022)

Editorial: Methods and applications in inflammation pharmacology
por: Schmidtchen, Artur, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aarbdlpe4lf4a7d2jo3jro3r0c